WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
Event-free survival extended with long-term finerenone in heart failure

Event-free survival extended with long-term finerenone in heart failure

by Elana GotkineLong-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief
Cardiovascular Diseases October 21,2024
Event-free survival extended with long-term finerenone in heart failure

Event-free survival extended with long-term finerenone in heart failure

by Elana GotkineLong-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief
Cardiovascular Diseases October 21,2024
GLP-1 weight-loss meds could interfere with endoscopy, colonoscopy

GLP-1 weight-loss meds could interfere with endoscopy, colonoscopy

by Ernie MundellFood left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy.Now, research finds this scenario is more like
Diabetes & Endocrinology October 21,2024
GLP-1 weight-loss meds could interfere with endoscopy, colonoscopy

GLP-1 weight-loss meds could interfere with endoscopy, colonoscopy

by Ernie MundellFood left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy.Now, research finds this scenario is more like
Diabetes & Endocrinology October 21,2024
New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions

New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions

byThe Mount Sinai HospitalKiNet functionalities. Credit:npj Systems Biology and Applications(2024). DOI: 10.1038/s41540-024-00442-5Researchers from the Icahn School of Medicine at Mo
Breakthroughs October 21,2024
New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions

New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions

byThe Mount Sinai HospitalKiNet functionalities. Credit:npj Systems Biology and Applications(2024). DOI: 10.1038/s41540-024-00442-5Researchers from the Icahn School of Medicine at Mo
Breakthroughs October 21,2024
Common diabetes drug shows promise for treating macular degeneration

Common diabetes drug shows promise for treating macular degeneration

byUniversity of Chicago Medical CenterMetformin 500mg tablets. Credit: public domainAge-related macular degeneration (AMD) is one of the leading causes of vision loss in adults over 50 in the Un
Ophthalmology October 21,2024
Common diabetes drug shows promise for treating macular degeneration

Common diabetes drug shows promise for treating macular degeneration

byUniversity of Chicago Medical CenterMetformin 500mg tablets. Credit: public domainAge-related macular degeneration (AMD) is one of the leading causes of vision loss in adults over 50 in the Un
Ophthalmology October 21,2024
New book explores the history of the phony cancer drug Krebiozen

New book explores the history of the phony cancer drug Krebiozen

by Sharita Forrest,University of Illinois at Urbana-ChampaignCredit: 3 Fields BooksIn March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—he
Oncology October 21,2024
New book explores the history of the phony cancer drug Krebiozen

New book explores the history of the phony cancer drug Krebiozen

by Sharita Forrest,University of Illinois at Urbana-ChampaignCredit: 3 Fields BooksIn March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—he
Oncology October 21,2024
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies

Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies

byLancaster UniversityThe brain of a 7-day-old fruit fly with Tau expressed in a neuronal circuit used by the fly in olfactory memory. The green outlines the neurons, which are starting to swell
Neurology October 21,2024
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies

Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies

byLancaster UniversityThe brain of a 7-day-old fruit fly with Tau expressed in a neuronal circuit used by the fly in olfactory memory. The green outlines the neurons, which are starting to swell
Neurology October 21,2024
Abortion pills will be controlled substances in Louisiana soon. Doctors have concerns

Abortion pills will be controlled substances in Louisiana soon. Doctors have concerns

by SARA CLINE and LAURA UNGARBottles of abortion pills mifepristone, left, and misoprostol, right, are displayed at a clinic in Des Moines, Iowa, Sept. 22, 2010. Credit: AP Photo/Charlie Neibergall, F
OB & GYN October 21,2024
Abortion pills will be controlled substances in Louisiana soon. Doctors have concerns

Abortion pills will be controlled substances in Louisiana soon. Doctors have concerns

by SARA CLINE and LAURA UNGARBottles of abortion pills mifepristone, left, and misoprostol, right, are displayed at a clinic in Des Moines, Iowa, Sept. 22, 2010. Credit: AP Photo/Charlie Neibergall, F
OB & GYN October 21,2024
Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph
ENT & HN October 21,2024
Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph
ENT & HN October 21,2024
Gilead licenses HIV-prevention drug to generic drugmakers

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income
Public Health & Prevention October 21,2024
Gilead licenses HIV-prevention drug to generic drugmakers

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income
Public Health & Prevention October 21,2024
Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo
Oncology October 21,2024
Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo
Oncology October 21,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com